Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Report

30 / 06 / 2012

FEAM’s contribution to a special edition on One Health

Italian Journal of Public Health, Issue: 2012, Vol.9, Nr.2

25 / 06 / 2012

Summary of session on ageing

(FEAM Madrid Spring Conference 4-5 May 2012)

25 / 06 / 2012

FEAM statement on data protection regulation

summary and proposed amendments

25 / 06 / 2012

Workshop on the Benefits of a Simplified and Coherent Clinical – Trials Framework in Europe

01 / 12 / 2011

FEAM statement on the EU Physical Agents Directive (2004/40/EC)

07 / 11 / 2011

Objectives and Opportunities for EU mental health policy

Account of the launch event of the FEAM statement on Mental Health Policy Issues (22 March 2011, European Parliament)

25 / 08 / 2011

Taking forward reform of the EU Clinical Trials Directive

Account of the launch event of the FEAM statement Opportunities and Challenges for Reforming the EU Clinical Trials Directive: an Academic Perspective (25 January 2011, European Parliament)

25 / 07 / 2011

European mental health policy: opportunities for science and innovation, challenges for implementation

(Robin Fears; Cyril Hoschl; The European Journal of Public Health 2011; doi: 10.1093/eurpub/ckr075). Free-access links to EJPH advance access page (October 2011 edition): Full Text: http://eurpub.oxfordjournals.org/cgi/content/full/ckr075? ijkey=Qt7fUZDrzfJIzbm&keytype=ref

25 / 07 / 2011

A response from FEAM to the European Commission consultation on the Green Paper ‘From Challenges to Opportunities

Towards a Common Strategic Framework for EU Research and Innovation funding'

25 / 05 / 2011

FEAM submission to the 2011 European Commission concept paper: revision of the ‘Clinical Trials Directive’ 2001/20/EC

25 / 05 / 2011

Mental health policy issues

the view from FEAM', an article by Robin Fears and Cyril Höschl on behalf of the FEAM Working Group, published in the January edition of EPA Journal (Eur Psychiatry 2011, vol 26, issue 1, pp. III-VI)

25 / 01 / 2011

FEAM Statement on Mental Health Policy Issues

25 / 11 / 2010

FEAM Statement ‘Opportunities and Challenges for Reforming the EU Clinical Trials Directive: an Academic Perspective’

25 / 09 / 2010

Consultation on Functioning of the Clinical Trials Directive

FEAM response

25 / 02 / 2010

Summary of the session on personalised medicine

Paris conference

31 / 10 / 2008

Report on Regenerative Medicine: basic and clinical research

Rome conference

25 / 12 / 2007

Report on the European Physical Agents Directive (2004/40/EC)

25 / 04 / 2006

Report on Health Associated Infections

(Brussels Conference)

25 / 01 / 2006

Update of the recommendations on Food Safety (labeling)

(Brussels Conference)

25 / 11 / 2005

Update of the recommendations on Tobacco Use

(Brussels Conference)

25 / 11 / 2005

Recommendations on the European Clinical Trials Directive

25 / 11 / 2004

Report on Tobacco Use

(Brussels Conference)

25 / 11 / 2004

Report on the stem cell session

(Rome Conference)

25 / 04 / 2004

Report on the childhood obesity session

(Cambridge Conference)

25 / 09 / 2003